Logo image of ALESA.PA

ECOSLOPS (ALESA.PA) Stock Fundamental Analysis

Europe - EPA:ALESA - FR0011490648 - Common Stock

0.82 EUR
0 (0%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

2

Overall ALESA gets a fundamental rating of 2 out of 10. We evaluated ALESA against 42 industry peers in the Commercial Services & Supplies industry. ALESA may be in some trouble as it scores bad on both profitability and health. ALESA has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALESA has reported negative net income.
In the past 5 years ALESA always reported negative net income.
In the past 5 years ALESA always reported negative operating cash flow.
ALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.55%, ALESA is doing worse than 76.19% of the companies in the same industry.
The Return On Equity of ALESA (-61.57%) is worse than 83.33% of its industry peers.
Industry RankSector Rank
ROA -11.55%
ROE -61.57%
ROIC N/A
ROA(3y)-12.21%
ROA(5y)-10.84%
ROE(3y)-51.34%
ROE(5y)-41.68%
ROIC(3y)N/A
ROIC(5y)N/A
ALESA.PA Yearly ROA, ROE, ROICALESA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

ALESA's Gross Margin of 66.05% is fine compared to the rest of the industry. ALESA outperforms 73.81% of its industry peers.
In the last couple of years the Gross Margin of ALESA has grown nicely.
ALESA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
ALESA.PA Yearly Profit, Operating, Gross MarginsALESA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

2

2. Health

2.1 Basic Checks

The number of shares outstanding for ALESA remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALESA has more shares outstanding
The debt/assets ratio for ALESA is higher compared to a year ago.
ALESA.PA Yearly Shares OutstandingALESA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALESA.PA Yearly Total Debt VS Total AssetsALESA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -1.39, we must say that ALESA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALESA (-1.39) is worse than 80.95% of its industry peers.
ALESA has a Debt/Equity ratio of 2.73. This is a high value indicating a heavy dependency on external financing.
ALESA has a worse Debt to Equity ratio (2.73) than 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.73
Debt/FCF N/A
Altman-Z -1.39
ROIC/WACCN/A
WACCN/A
ALESA.PA Yearly LT Debt VS Equity VS FCFALESA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

ALESA has a Current Ratio of 1.81. This is a normal value and indicates that ALESA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALESA (1.81) is better than 73.81% of its industry peers.
ALESA has a Quick Ratio of 1.49. This is a normal value and indicates that ALESA is financially healthy and should not expect problems in meeting its short term obligations.
ALESA's Quick ratio of 1.49 is fine compared to the rest of the industry. ALESA outperforms 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.49
ALESA.PA Yearly Current Assets VS Current LiabilitesALESA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.92% over the past year.
The Revenue has grown by 12.05% in the past year. This is quite good.
Measured over the past years, ALESA shows a small growth in Revenue. The Revenue has been growing by 5.43% on average per year.
EPS 1Y (TTM)57.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.74%
Revenue 1Y (TTM)12.05%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%12.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALESA.PA Yearly Revenue VS EstimatesALESA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALESA.PA Yearly EPS VS EstimatesALESA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 -1

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALESA. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 1.61, which indicates a rather cheap valuation of ALESA.
100.00% of the companies in the same industry are more expensive than ALESA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.89, ALESA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.61
ALESA.PA Price Earnings VS Forward Price EarningsALESA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALESA.PA Per share dataALESA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALESA!.
Industry RankSector Rank
Dividend Yield N/A

ECOSLOPS

EPA:ALESA (9/26/2025, 7:00:00 PM)

0.82

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)10-30 2025-10-30
Inst Owners12.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.26M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.61
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 1.08
EV/EBITDA N/A
EPS(TTM)-0.6
EYN/A
EPS(NY)0.51
Fwd EY62.18%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.22
BVpS0.97
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.55%
ROE -61.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.05%
FCFM N/A
ROA(3y)-12.21%
ROA(5y)-10.84%
ROE(3y)-51.34%
ROE(5y)-41.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
F-ScoreN/A
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 2.73
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.49
Altman-Z -1.39
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.74%
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.05%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%12.74%
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1271.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A